RNA-targeting enzyme expands the CRISPR toolkit
Exploring diversity among bacterial immune systems, McGovern Institute scientists uncovere a programmable system for precisely targeting and modifying RNA.
Search Stories
New programmable gene editing proteins found outside of CRISPR systems
Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
School of Science welcomes new faculty
Eleven professors begin in the departments of Biology; Brain and Cognitive Sciences; Chemistry; Earth, Atmospheric and Planetary Sciences; Mathematics; and Physics.
Scientists harness human protein to deliver molecular medicines to cells
Made of components found in the human body, the programmable system is a step toward safer, targeted delivery of gene editing and other molecular therapeutics.
New device can diagnose Covid-19 from saliva samples
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
Inaugural fund supports early-stage collaborations between MIT and Jordan
MIT-Jordan Abdul Hameed Shoman Foundation Seed Fund winners announced.
SMART researchers develop a method for rapid, accurate virus detection
Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
New face mask prototype can detect Covid-19 infection
The sensor technology could also be used to create clothing that detects a variety of pathogens and other threats.
A new technique for correcting disease-causing mutations
Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
Accelerating the pace of engineered cell therapies, from lab to bedside
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Using CRISPR as a research tool to develop cancer treatments
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
MIT team improving gene therapies wins Sloan health care prize
Kano Therapeutics was one of eight finalists to pitch at the virtual competition.
Catching cancer in the act
Using CRISPR technology, researchers are tracking the lineage of individual cancer cells as they proliferate and metastasize in real-time.
Four MIT scientists honored with 2021 National Academy of Sciences awards
Pablo Jarillo-Herrero, Aviv Regev, Susan Solomon, and Feng Zhang are the recipients of distinguished awards for major contributions to science.
Regulating the regulators
Tiny microRNAs help destroy unwanted messenger RNAs in cells. New research finds how the body keeps them in check.